PARIS–(BUSINESS WIRE)–TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced today the publication of its manuscript detailing preclinical and clinical evaluations of SETALIUMTM Vascular Sealant, the company’s first synthetic, biodegradable, on-demand, light-activated sealant. The results of these evaluations, published in The Journal of Cardiovascular Surgery on May 10th, 2019, […]
Other News
MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission
PLANO, Texas, May 16, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring. The patent covers use of the technology and methodology for arrhythmia monitoring and for remote or […]
Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
DUBLIN – May 16, 2019 – Medtronic plc (NYSE:MDT), a global leader in percutaneous coronary intervention (PCI) innovation, today announced its entrance into the guide extension catheter market with the global launch of the Telescope(TM) Guide Extension Catheter, a newly designed catheter used to provide additional backup support and access to […]
Medical Device Industry Veteran Rob Abrams to Join Evolve Team
SOLANA BEACH, Calif.–(BUSINESS WIRE)–Evolve Medtech Partners, a medical device development company and incubator, is pleased to announce that Rob Abrams has joined the company as a partner. “We’ve had the pleasure of getting to know Rob over a number of years and recognize him as an exceptionally talented executive with an impressive […]
Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System, a unique Thoracic Endovascular Aortic Repair (TEVAR) solution combining new levels of control […]
Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
SANTA CLARA, Calif., May 15, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated […]
Teleflex to participate at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR) 2019 with its complex PCI product portfolio and the newly acquired MANTA™ Vascular Closure Device
WAYNE, Pa., May 15, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will showcase its complex PCI product portfolio, the Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) and the newly acquired MANTA™ Vascular Closure […]
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
EDEN PRAIRIE, Minn., May 15, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware-based health system, Beebe Healthcare, has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow system. “As heart failure and other conditions that contribute to fluid overload expand worldwide, CHF continues to […]
Elixir Medical to Present 9 and 12-Month Clinical and Imaging Data for the DynamX Bioadaptor, Showcasing the Next Frontier Beyond Stenting at EuroPCR 2019
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will release at EuroPCR in Paris 9 and 12-month clinical and imaging data for the DynamX™ Novolimus-eluting Bioadaptor System, a next-generation coronary intervention system designed to treat blocked arteries […]
InspireMD Announces First Quarter 2019 Financial Results
TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced results for the first quarter ending March 31, 2019. First Quarter 2019 and […]



